CME GROUP INC (CME) Stock Fundamental Analysis

NASDAQ:CME • US12572Q1058

325.13 USD
-1.33 (-0.41%)
At close: Mar 3, 2026
324.24 USD
-0.89 (-0.27%)
After Hours: 3/3/2026, 8:02:48 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CME. CME was compared to 238 industry peers in the Capital Markets industry. CME has an average financial health and profitability rating. CME is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CME had positive earnings in the past year.
  • In the past year CME had a positive cash flow from operations.
  • In the past 5 years CME has always been profitable.
  • CME had a positive operating cash flow in 4 of the past 5 years.
CME Yearly Net Income VS EBIT VS OCF VS FCFCME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

1.2 Ratios

  • With a Return On Assets value of 1.99%, CME perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
  • CME has a better Return On Equity (13.18%) than 72.27% of its industry peers.
  • With an excellent Return On Invested Capital value of 18.56%, CME belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
  • CME had an Average Return On Invested Capital over the past 3 years of 18.73%. This is significantly above the industry average of 7.27%.
Industry RankSector Rank
ROA 1.99%
ROE 13.18%
ROIC 18.56%
ROA(3y)2.34%
ROA(5y)1.97%
ROE(3y)13.02%
ROE(5y)11.7%
ROIC(3y)18.73%
ROIC(5y)14.69%
CME Yearly ROA, ROE, ROICCME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 32.91%, CME is in the better half of the industry, outperforming 77.31% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CME has declined.
  • With an excellent Operating Margin value of 80.16%, CME belongs to the best of the industry, outperforming 98.74% of the companies in the same industry.
  • CME's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 80.16%
PM (TTM) 32.91%
GM N/A
OM growth 3Y4.02%
OM growth 5Y7.87%
PM growth 3Y-3.77%
PM growth 5Y-4.62%
GM growth 3YN/A
GM growth 5YN/A
CME Yearly Profit, Operating, Gross MarginsCME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, CME has more shares outstanding
  • Compared to 5 years ago, CME has more shares outstanding
  • Compared to 1 year ago, CME has an improved debt to assets ratio.
CME Yearly Shares OutstandingCME Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CME Yearly Total Debt VS Total AssetsCME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • CME has an Altman-Z score of 0.73. This is a bad value and indicates that CME is not financially healthy and even has some risk of bankruptcy.
  • CME has a Altman-Z score of 0.73. This is comparable to the rest of the industry: CME outperforms 49.16% of its industry peers.
  • CME has a debt to FCF ratio of 0.85. This is a very positive value and a sign of high solvency as it would only need 0.85 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.85, CME belongs to the top of the industry, outperforming 89.08% of the companies in the same industry.
  • A Debt/Equity ratio of 0.12 indicates that CME is not too dependend on debt financing.
  • CME has a Debt to Equity ratio of 0.12. This is in the better half of the industry: CME outperforms 77.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.85
Altman-Z 0.73
ROIC/WACCN/A
WACCN/A
CME Yearly LT Debt VS Equity VS FCFCME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • A Current Ratio of 1.02 indicates that CME should not have too much problems paying its short term obligations.
  • CME has a Current ratio (1.02) which is in line with its industry peers.
  • CME has a Quick Ratio of 1.02. This is a normal value and indicates that CME is financially healthy and should not expect problems in meeting its short term obligations.
  • CME's Quick ratio of 1.02 is in line compared to the rest of the industry. CME outperforms 46.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
CME Yearly Current Assets VS Current LiabilitesCME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • CME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.26%, which is quite good.
  • Measured over the past years, CME shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.74% on average per year.
  • CME shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.06%.
  • Measured over the past years, CME shows a quite strong growth in Revenue. The Revenue has been growing by 19.33% on average per year.
EPS 1Y (TTM)9.26%
EPS 3Y12%
EPS 5Y10.74%
EPS Q2Q%9.92%
Revenue 1Y (TTM)20.06%
Revenue growth 3Y19.31%
Revenue growth 5Y19.33%
Sales Q2Q%8.09%

3.2 Future

  • CME is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.89% yearly.
  • CME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.26% yearly.
EPS Next Y5.6%
EPS Next 2Y5.94%
EPS Next 3Y6.61%
EPS Next 5Y4.89%
Revenue Next Year6.64%
Revenue Next 2Y6.11%
Revenue Next 3Y6.51%
Revenue Next 5Y5.26%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CME Yearly Revenue VS EstimatesCME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
CME Yearly EPS VS EstimatesCME Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • CME is valuated quite expensively with a Price/Earnings ratio of 29.00.
  • Based on the Price/Earnings ratio, CME is valued a bit more expensive than 73.95% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.83, CME is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 27.46, the valuation of CME can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CME indicates a slightly more expensive valuation: CME is more expensive than 65.13% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of CME to the average of the S&P500 Index (24.95), we can say CME is valued inline with the index average.
Industry RankSector Rank
PE 29
Fwd PE 27.46
CME Price Earnings VS Forward Price EarningsCME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CME is valued cheaply inside the industry as 83.19% of the companies are valued more expensively.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as CME.
Industry RankSector Rank
P/FCF 28.71
EV/EBITDA 12.63
CME Per share dataCME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CME has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.17
PEG (5Y)2.7
EPS Next 2Y5.94%
EPS Next 3Y6.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • CME has a Yearly Dividend Yield of 1.60%. Purely for dividend investing, there may be better candidates out there.
  • CME's Dividend Yield is slightly below the industry average, which is at 6.44.
  • CME's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.6%

5.2 History

  • The dividend of CME is nicely growing with an annual growth rate of 16.00%!
  • CME has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CME has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)16%
Div Incr Years11
Div Non Decr Years11
CME Yearly Dividends per shareCME Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8 10

5.3 Sustainability

  • CME pays out 104.85% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of CME is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP104.85%
EPS Next 2Y5.94%
EPS Next 3Y6.61%
CME Yearly Income VS Free CF VS DividendCME Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
CME Dividend Payout.CME Dividend Payout, showing the Payout Ratio.CME Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CME GROUP INC

NASDAQ:CME (3/3/2026, 8:02:48 PM)

After market: 324.24 -0.89 (-0.27%)

325.13

-1.33 (-0.41%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-04
Earnings (Next)04-21
Inst Owners91.62%
Inst Owner Change1.79%
Ins Owners0.24%
Ins Owner Change0%
Market Cap117.24B
Revenue(TTM)12.26B
Net Income(TTM)3.72B
Analysts71
Price Target308.13 (-5.23%)
Short Float %1.5%
Short Ratio2.52
Dividend
Industry RankSector Rank
Dividend Yield 1.6%
Yearly Dividend9.97
Dividend Growth(5Y)16%
DP104.85%
Div Incr Years11
Div Non Decr Years11
Ex-Date03-10
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.59%
Min EPS beat(2)0.43%
Max EPS beat(2)0.76%
EPS beat(4)3
Avg EPS beat(4)0.49%
Min EPS beat(4)-1.28%
Max EPS beat(4)2.05%
EPS beat(8)6
Avg EPS beat(8)0.72%
EPS beat(12)10
Avg EPS beat(12)0.95%
EPS beat(16)14
Avg EPS beat(16)1.13%
Revenue beat(2)0
Avg Revenue beat(2)-0.83%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)-0.54%
Revenue beat(4)0
Avg Revenue beat(4)-0.98%
Min Revenue beat(4)-1.72%
Max Revenue beat(4)-0.54%
Revenue beat(8)0
Avg Revenue beat(8)-0.81%
Revenue beat(12)3
Avg Revenue beat(12)7.34%
Revenue beat(16)7
Avg Revenue beat(16)10.88%
PT rev (1m)5.04%
PT rev (3m)5.7%
EPS NQ rev (1m)-0.15%
EPS NQ rev (3m)2.89%
EPS NY rev (1m)0.1%
EPS NY rev (3m)1.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.54%
Revenue NY rev (1m)1.26%
Revenue NY rev (3m)2.41%
Valuation
Industry RankSector Rank
PE 29
Fwd PE 27.46
P/S 10.38
P/FCF 28.71
P/OCF 28.18
P/B 4.16
P/tB N/A
EV/EBITDA 12.63
EPS(TTM)11.21
EY3.45%
EPS(NY)11.84
Fwd EY3.64%
FCF(TTM)11.33
FCFY3.48%
OCF(TTM)11.54
OCFY3.55%
SpS31.32
BVpS78.18
TBVpS-6.01
PEG (NY)5.17
PEG (5Y)2.7
Graham Number140.42
Profitability
Industry RankSector Rank
ROA 1.99%
ROE 13.18%
ROCE 24.11%
ROIC 18.56%
ROICexc 19.93%
ROICexgc 150.6%
OM 80.16%
PM (TTM) 32.91%
GM N/A
FCFM 36.16%
ROA(3y)2.34%
ROA(5y)1.97%
ROE(3y)13.02%
ROE(5y)11.7%
ROIC(3y)18.73%
ROIC(5y)14.69%
ROICexc(3y)20.74%
ROICexc(5y)16.19%
ROICexgc(3y)290.88%
ROICexgc(5y)224.49%
ROCE(3y)24.31%
ROCE(5y)19.07%
ROICexgc growth 3Y16.89%
ROICexgc growth 5Y15.23%
ROICexc growth 3Y24.21%
ROICexc growth 5Y29.59%
OM growth 3Y4.02%
OM growth 5Y7.87%
PM growth 3Y-3.77%
PM growth 5Y-4.62%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.85
Debt/EBITDA 0.37
Cap/Depr 23.26%
Cap/Sales 0.68%
Interest Coverage 66.76
Cash Conversion 44.34%
Profit Quality 109.88%
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 0.73
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.26%
EPS 3Y12%
EPS 5Y10.74%
EPS Q2Q%9.92%
EPS Next Y5.6%
EPS Next 2Y5.94%
EPS Next 3Y6.61%
EPS Next 5Y4.89%
Revenue 1Y (TTM)20.06%
Revenue growth 3Y19.31%
Revenue growth 5Y19.33%
Sales Q2Q%8.09%
Revenue Next Year6.64%
Revenue Next 2Y6.11%
Revenue Next 3Y6.51%
Revenue Next 5Y5.26%
EBIT growth 1Y12.23%
EBIT growth 3Y24.1%
EBIT growth 5Y28.72%
EBIT Next Year10.74%
EBIT Next 3Y9.04%
EBIT Next 5Y6.41%
FCF growth 1Y12.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.95%
OCF growth 3YN/A
OCF growth 5YN/A

CME GROUP INC / CME FAQ

What is the ChartMill fundamental rating of CME GROUP INC (CME) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CME.


What is the valuation status of CME GROUP INC (CME) stock?

ChartMill assigns a valuation rating of 2 / 10 to CME GROUP INC (CME). This can be considered as Overvalued.


Can you provide the profitability details for CME GROUP INC?

CME GROUP INC (CME) has a profitability rating of 6 / 10.


What is the earnings growth outlook for CME GROUP INC?

The Earnings per Share (EPS) of CME GROUP INC (CME) is expected to grow by 5.6% in the next year.


Can you provide the dividend sustainability for CME stock?

The dividend rating of CME GROUP INC (CME) is 4 / 10 and the dividend payout ratio is 104.85%.